Skip to main content
SpringerLink
Log in

No Significant Difference in Antigenicity or Tissue Transglutaminase Substrate Specificity of Irish and US Wheat Gliadins

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The prevalence of clinical celiac disease has been shown to vary both across time and between genetically similar populations. Differences in wheat antigenicity and transglutaminase substrate properties are a possible explanation for these differences. This study assessed the antigenicity and transglutaminase substrate specificities of gliadins from regions of high and low celiac disease prevalence. Gliadin was extracted from three commercial US wheat sources and two Irish sources. SDS-PAGE and western blotting revealed minor, but significant variations in the gliadin extracts. However, ELISA showed no difference in the antigenicity of these gliadins. Transglutaminase pretreatment of gliadin resulted in no significant change in gliadin antigenicity and kinetic studies showed that the K ms of the various gliadins were very similar. Purified IgA and IgG had no effect on transglutaminase activity. In summary, minor variations in wheat gliadins are unlikely to explain the observed differences in disease expression across genetically similar populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Godkin A, Jewell D: The pathogenesis of celiac disease. Gastroenterology 115:206–210, 1998

    Google Scholar 

  2. Wieser H: The precipitating factor in celiac disease. Baillieres Clin Gastroenterol 9:191–207, 1995

    Google Scholar 

  3. Sturgess RP, Ellis HJ, Ciclitira PJ: Cereal chemistry, molecular biology, and toxicity in celiac disease. Gut 32:1055–1060, 1991

    Google Scholar 

  4. Saalman R, Wold AE, Dahlgren UI, Fallstrom SP, Hanson LA, Ahlstedt S: Antibody-dependent cell-mediated cytotoxicity to gliadin-coated cells with sera from children with celiac disease. Scand J Immunol 47:37–42, 1998

    Google Scholar 

  5. Wieser H: Relation between gliadin structure and celiac toxicity. Acta Paediatr Suppl 412:3–9, 1996

    Google Scholar 

  6. Maiuri L, Troncone R, Mayer M, Coletta S, Picarelli A, De Vincenzi M, Pavone V, Auricchio S: In vitro activities of A-gliadin-related synthetic peptides: Damaging effect on the atrophic celiac mucosa and activation of mucosal immune response in the treated celiac mucosa. Scand J Gastroenterol 31:247–253, 1996

    Google Scholar 

  7. Tighe MR, Ciclitira PJ: The gluten-host interaction. Baillieres Clin Gastroenterol 9:211–230, 1995

    Google Scholar 

  8. Sulkanen S, Halttunen T, Laurila K, Kolho KL, Korponay-Szabo IR, Sarnesto A, Savilahti E, Collin P, Maki M: Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 115:1322–1328, 1998

    Google Scholar 

  9. Fraser-Reynolds KA, Butzner JD, Stephure DK, Trussell RA, Scott RB: Use of immunoglobulin A-antiendomysial antibody to screen for celiac disease in North American children with type 1 diabetes. Diabetes Care 21:1985–1989, 1998

    Google Scholar 

  10. Volta U, Molinaro N, de Franceschi L, Fratangelo D, Bianchi FB: IgA anti-endomysial antibodies on human umbilical cord tissue for celiac disease screening. Save both money and monkeys. Dig Dis Sci 40:1902–1905, 1995

    Google Scholar 

  11. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D: Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3:797–801, 1997

    Google Scholar 

  12. Aeschlimann D, Paulsson M: Cross-linking of laminin-nidogen complexes by tissue transglutaminase. A novel mechanism for basement membrane stabilization. J Biol Chem 266:15308–15317, 1991

    Google Scholar 

  13. Bruce SE, Bjarnason I, Peters TJ: Human jejunal transglutaminase: demonstration of activity, enzyme kinetics and substrate specificity with special relation to gliadin and celiac disease. Clin Sci 68:573–579, 1985

    Google Scholar 

  14. Stevens FM, Egan-Mitchell B, Cryan E, McCarthy CF, McNicholl B: Decreasing incidence of celiac disease. Arch Dis Child 62:465–468, 1987

    Google Scholar 

  15. Logan RF, Rifkind EA, Busuttil A, Gilmour HM, Ferguson A: Prevalence and “incidence” of celiac disease in Edinburgh and the Lothian region of Scotland. Gastroenterology 90:334–342, 1986

    Google Scholar 

  16. Fasano A: Where have all the American celiacs gone? Acta Paediatr Suppl 412:20–24, 1996

    Google Scholar 

  17. Talley NJ, Valdovinos M, Petterson TM, Carpenter HA, Melton LJ 3rd: Epidemiology of celiac sprue: A community-based study. Am J Gastroenterol 89:843–846, 1994

    Google Scholar 

  18. Rossi TM, Albini CH, Kumar V: Incidence of celiac disease identified by the presence of serum endomysial antibodies in children with chronic diarrhea, short stature, or insulin-dependent diabetes mellitus. J Pediatr 123:262–264, 1993

    Google Scholar 

  19. Not T, Horvath K, Hill ID, Partanen J, Hammed A, Magazzu G, Fasano A: Celiac disease risk in the USA: High prevalence of antiendomysium antibodies in healthy blood donors. Scand J Gastroenterol 33:494–498, 1998

    Google Scholar 

  20. Talal AH, Murray JA, Goeken JA, Sivitz WI: Celiac disease in an adult population with insulin-dependent diabetes mellitus: Use of endomysial antibody testing. Am J Gastroenterol 92:1280–1284, 1997

    Google Scholar 

  21. Weile B, Cavell B, Nivenius K, Krasilnikoff PA: Striking differences in the incidence of childhood celiac disease between Denmark and Sweden: A plausible explanation. J Pediatr Gastroenterol Nutr 21:64–68, 1995

    Google Scholar 

  22. Ascher H, Holm K, Kristiansson B, Maki M: Different features of celiac disease in two neighboring countries. Arch Dis Child 69:375–380, 1993

    Google Scholar 

  23. Sjostrom H, Friis SU, Noren O, Anthonsen D: Purification and characterisation of antigenic gliadins in celiac disease. Clin Chim Acta 207:227–237, 1992

    Google Scholar 

  24. Lorand L, Lockridge OM, Campbell LK, Myhrman R, Bruner-Lorand J: Transamidating enzymes. II. A continuous fluorescent method suited for automating measurements of factor XIII in plasma. Anal Biochem 44:221–231, 1971

    Google Scholar 

  25. Dixon M: The graphical determination of Km and Ki. Biochem J 129:197–202, 1972

    Google Scholar 

  26. Barnes RM, Lewis-Jones MS: Isotype distribution and serial levels of antibodies reactive with dietary protein antigens in dermatitis herpetiformis. J Clin Lab Immunol 30:87–91, 1989

    Google Scholar 

  27. Hvatum M, Scott H, Brandtzaeg P: Serum IgG subclass antibodies to a variety of food antigens in patients with celiac disease. Gut 33:632–638, 1992

    Google Scholar 

  28. Volta U, Lazzari R, Bianchi FB, Lenzi M, Baldoni AM, Cassani F, Collina A, Pisi E: Antibodies to dietary antigens in celiac disease. Scand J Gastroenterol 21:935–940, 1986

    Google Scholar 

  29. Borner H, Osman AA, Meergans T, Weiske T, Mothes T: Isolation of antigens recognized by celiac disease autoantibodies and their use in enzyme immunoassay of endomysium and reticulin antibody-positive human sera. Clin Exp Immunol 106:344–350, 1996

    Google Scholar 

  30. Wang JY, Johnson LR: Role of transglutaminase and protein cross-linking in the repair of mucosal stress erosions. Am J Physiol 262:G818–G825, 1992

    Google Scholar 

  31. Molberg O, McAdam SN, Korner R, Quarsten H, Kristiansen C, Madsen L, Fugger L, Scott H, Noren O, Roepstorff P, Lundin KE, Sjostrom H, Sollid LM: Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac. Nat Med 4:713–717, 1998

    Google Scholar 

  32. Halstensen TS, Hvatum M, Scott H, Fausa O, Brandtzaeg P: Association of subepithelial deposition of activated complement and immunoglobulin G and M response to gluten in celiac disease. Gastroenterology 102:751–759, 1992

    Google Scholar 

  33. Shiner M, Ballard J: Antigen-antibody reactions in jejunal mucosa in childhood celiac disease after gluten challenge. Lancet 1:1202–1205, 1972

    Google Scholar 

  34. Lancaster-Smith M, Joyce S, Kumar P. Immunoglobulins in the jejunal mucosa in adult celiac disease and dermatitis herpetiformis after the reintroduction of dietary gluten. Gut 18:887–891, 1977

    Google Scholar 

  35. Karpati S, Burgin-Wolff A, Krieg T, Meurer M, Stolz W, Braun-Falco O: Binding to human jejunum of serum IgA antibody from children with celiac disease. Lancet 336:1335–1338, 1990

    Google Scholar 

  36. Unsworth DJ, Leonard JN, Hobday CM, Griffiths CE, Powles AV, Haffenden GP, Fry L: Gliadins bind to reticulin in a lectin-like manner. Arch Dermatol Res 279:232–235, 1987

    Google Scholar 

  37. Halttunen T, Maki M: Serum immunoglobulin A from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation. Gastroenterology 116:566–572, 1999

    Google Scholar 

  38. Nunes I, Gleizes PE, Metz CN, Rifkin DB: Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J Cell Biol 136:1151–1163, 1997

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Gastroenterology, Boston Medical Center and Boston University School of Medicine, Boston, Massachusetts

    Andrew P. Keaveny, Gwynneth D. Offner, Emma Bootle & David P. Nunes

Authors
  1. Andrew P. Keaveny
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gwynneth D. Offner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Emma Bootle
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David P. Nunes
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Keaveny, A.P., Offner, G.D., Bootle, E. et al. No Significant Difference in Antigenicity or Tissue Transglutaminase Substrate Specificity of Irish and US Wheat Gliadins. Dig Dis Sci 45, 755–762 (2000). https://doi.org/10.1023/A:1005404012558

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005404012558

Search

Navigation